chr16-83915471-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012213.3(MLYCD):​c.1464A>G​(p.Gln488Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00205 in 1,612,274 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 26 hom. )

Consequence

MLYCD
NM_012213.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.81

Publications

2 publications found
Variant links:
Genes affected
MLYCD (HGNC:7150): (malonyl-CoA decarboxylase) The product of this gene catalyzes the breakdown of malonyl-CoA to acetyl-CoA and carbon dioxide. Malonyl-CoA is an intermediate in fatty acid biosynthesis, and also inhibits the transport of fatty acyl CoAs into mitochondria. Consequently, the encoded protein acts to increase the rate of fatty acid oxidation. It is found in mitochondria, peroxisomes, and the cytoplasm. Mutations in this gene result in malonyl-CoA decarboyxlase deficiency. [provided by RefSeq, Jul 2008]
MLYCD Gene-Disease associations (from GenCC):
  • malonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 16-83915471-A-G is Benign according to our data. Variant chr16-83915471-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 320740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00807 (1229/152350) while in subpopulation AFR AF = 0.0268 (1112/41570). AF 95% confidence interval is 0.0254. There are 13 homozygotes in GnomAd4. There are 587 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLYCDNM_012213.3 linkc.1464A>G p.Gln488Gln synonymous_variant Exon 5 of 5 ENST00000262430.6 NP_036345.2 O95822-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLYCDENST00000262430.6 linkc.1464A>G p.Gln488Gln synonymous_variant Exon 5 of 5 1 NM_012213.3 ENSP00000262430.4 O95822-1

Frequencies

GnomAD3 genomes
AF:
0.00806
AC:
1227
AN:
152232
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00379
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00241
AC:
588
AN:
243998
AF XY:
0.00191
show subpopulations
Gnomad AFR exome
AF:
0.0271
Gnomad AMR exome
AF:
0.00264
Gnomad ASJ exome
AF:
0.00121
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000628
Gnomad OTH exome
AF:
0.00284
GnomAD4 exome
AF:
0.00142
AC:
2078
AN:
1459924
Hom.:
26
Cov.:
30
AF XY:
0.00135
AC XY:
979
AN XY:
726302
show subpopulations
African (AFR)
AF:
0.0303
AC:
1013
AN:
33474
American (AMR)
AF:
0.00273
AC:
122
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000765
AC:
20
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51536
Middle Eastern (MID)
AF:
0.00539
AC:
31
AN:
5754
European-Non Finnish (NFE)
AF:
0.000631
AC:
702
AN:
1111978
Other (OTH)
AF:
0.00310
AC:
187
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
140
280
421
561
701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00807
AC:
1229
AN:
152350
Hom.:
13
Cov.:
33
AF XY:
0.00788
AC XY:
587
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.0268
AC:
1112
AN:
41570
American (AMR)
AF:
0.00379
AC:
58
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68034
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00351
Hom.:
4
Bravo
AF:
0.00913
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of malonyl-CoA decarboxylase Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 16, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:1
Apr 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
6.9
DANN
Benign
0.65
PhyloP100
3.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1127368; hg19: chr16-83949076; COSMIC: COSV99299517; API